Goldman Sachs: Oil Prices Still Set To Hit $140
By Julianne Geiger - Jul 07, 2022, 6:30 PM CDTOil prices may be dropping, but oil is still headed for $140 per barrel, Goldman Sachs told CNBC on Thursday, and could even hit $140 in the face of a recession.
“$140 is still our base case because, unlike equity, which are anticipatory assets, commodities need to solve for today’s mismatched supply and demand,” energy analyst Damien Courvalin said, who compared today’s market to the recession in 2008.
At that time, oil prices rallied even during the first six months of the market downturn, bolstered by tight supplies as inventories continued to draw down, Courvalin explained. Eventually, oil prices were dragged down by the slowing economy. Goldman sees that happening again, even if we are headed for a recession—at least at the start of a recession.
Robust demand and a tight market this time around is compounded by years of underinvestment in oil exploration, creating this long-term supply issue that is immune to any speedy remedy. Goldman still sees Brent sinking to $85 if GDP growth outside China reaches zero, but tight crude oil supplies should put a floor under the price slide.
Goldman’s predictions for $140 oil as its base case comes even as crude oil prices slid this week, and even as some fear a recession. WTI and Brent crude rallied on Thursday, managing to regain ground that was lost earlier in the week that saw both benchmarks break below $100 per barrel. The market fundamentally remains tight, but temporary factors including China’s recently announced plan to consider a $220 billion stimulus with bond sales and fears of a recession have swung oil wildly this week.
By Thursday afternoon, both benchmarks had made significant gains. WTI was trading up 4.23% to $102.70, with Brent crude trading up 3.95% to $104.70 per barrel.
“This is an environment where we need a decade of investment ahead,” the Goldman analyst told CNBC.
By Julianne Geiger for Oilprice.com
- Forums
- ASX - By Stock
- BYE
- $US140/b
$US140/b
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.9¢ |
Change
-0.001(1.67%) |
Mkt cap ! $63.64M |
Open | High | Low | Value | Volume |
5.8¢ | 6.0¢ | 5.8¢ | $2.047K | 34.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 97687 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 331777 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 97687 | 0.059 |
1 | 58620 | 0.058 |
2 | 200000 | 0.056 |
2 | 1200000 | 0.055 |
3 | 1838999 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 300000 | 1 |
0.066 | 78500 | 1 |
0.067 | 40000 | 1 |
0.070 | 25555 | 2 |
0.073 | 14000 | 1 |
Last trade - 15.56pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
5.8¢ |
  |
Change
-0.001 ( 1.69 %) |
|||
Open | High | Low | Volume | ||
5.8¢ | 5.8¢ | 5.8¢ | 10526 | ||
Last updated 12.21pm 06/05/2024 ? |
Featured News
BYE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online